![](/cdn/assets/images/search/clock.png)
We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Chromogenex | LSE:CGX | London | Ordinary Share | GB00B0B7XX32 | ORD 1P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 0.325 | 0.00 | 01:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
0 | 0 | N/A | 0 |
RNS Number:1726Y Chromogenex PLC 12 June 2007 For immediate release 12 June 2007 Chromogenex plc AGM and Trading statement At the AGM of the company to be held later on today, Peter McGuinness, Chairman of Chromogenex plc, will make the following statement: "The company reported results for the year ended 31st December 2006 in March which showed a 36% increase in sales and 282% increase in profit after tax. The final quarter of 2006 was the strongest to date resulting from continued demand for the Chromolite Intense Pulsed Light system and a renewed interest in the Nlite laser system from both existing and new markets. "The recent launch of the Smoothshapes product for the treatment of cellulite has been successful. The product was launched in the US at the recent American Society for Lasers in Medicine conference by Smoothshapes Inc and sales to date are ahead of expectations. "Also we are pleased to announce the successful launch of US FDA approved Chromolite S, with an order for 100 systems, the largest single order for the company to date. This is a significant order for Chromogenex with delivery of the systems due to take place in the 3rd quarter of this year. Chromolite S is the next generation of the top selling Chromolite, and interest from distributors has been encouraging. Whilst some have held off orders of the previous model in the first half, in anticipation of the S model, current orders are ahead of expectations. Chromolite S uses a Sapphire waveguide and Smartlite technology which doubles the energy output and enhances skin cooling to increase safety and efficacy. This allows it to compete with high end IPL systems whilst maintaining its competitive pricing model. "Further development has also been completed on the Nlite and sales of this product continue to increase in line with internal forecasts. The renewed interest in Nlite seen in the last quarter of 2006 has continued and the company is positive about the prospects going forward. "2006 was a successful year for the company and has laid the foundation for expansion of its product line and distribution network. The company plans to introduce some exciting new products in the second half of 2007 which will strengthen its distributor relationships by offering a comprehensive product range and broaden its revenue base." For further information: Chromogenex plc 020 8434 0540 Peter McGuinness, Chairman 07775 834 777 Blue Oar 020 7448 4400 Jerry Keen Threadneedle Communications 020 7936 9605 Graham Herring/Josh Royston 07793 839 024 This information is provided by RNS The company news service from the London Stock Exchange END MSCBCGDLXBBGGRB
1 Year Chromogenex Chart |
1 Month Chromogenex Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions